Barry James J 4
4 · EyePoint Pharmaceuticals, Inc. · Filed May 14, 2018
Insider Transaction Report
Form 4
Barry James J
Director
Transactions
- Exercise/Conversion
Common Stock
2018-05-07+12,500→ 12,500 total - Exercise/Conversion
Deferred Stock Units
2018-05-07−12,500→ 0 total→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]Each deferred stock unit represents the right to receive one share of the common stock of EyePoint Pharmaceuticals, Inc.
- [F2]On December 15, 2017, the reporting person was granted 12,500 deferred stock units, which deferred stock units vested in full in connection with the effectiveness of Mr. Barry's resignation from the Board on May 7, 2018.